Sterile Injectable Contract Manufacturing Market

Sterile Injectable Contract Manufacturing Market Size, Share, Growth Analysis, By Molecule Type Outlook(Small Molecule, Large Molecule), By Therapeutic Application Outlook(Cancer, Diabetes), By Route of Administration Outlook(Subcutaneous (SC), Intravenous (IV)), By End-use Outlook(Pharmaceutical Companies, Biopharmaceutical Companies), By Region(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35I2298 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Sterile Injectable Contract Manufacturing Market Insights

Market Overview:

The global market for contract manufacturing of sterile injectables was valued at approximately $12.89 billion in 2022, with a projected compound annual growth rate (CAGR) of 12.1% expected from 2023 to 2030. The growth of biopharmaceuticals like vaccines, cell and gene therapies has contributed to increased production of injectable drug products worldwide. Additionally, the rising prevalence of chronic diseases, along with quicker approval processes for sterile injectables compared to other drug categories, is further fueling the demand for injectable medications. This surge in demand has led to an increase in outsourcing agreements between contract manufacturers and original drug developers, thus driving the growth of the sterile injectable contract manufacturing sector.

Sterile Injectable Contract Manufacturing Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Sterile Injectable Contract Manufacturing was estimated to be valued at US$ XX Mn in 2021.

The Sterile Injectable Contract Manufacturing Market is estimated to grow at a CAGR of XX% by 2028.

The Sterile Injectable Contract Manufacturing Market is segmented on the basis of Molecule Type Outlook, Therapeutic Application Outlook, Route of Administration Outlook, End-use Outlook, Region.

Based on region, the Sterile Injectable Contract Manufacturing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Sterile Injectable Contract Manufacturing Market are Baxter, Catalent, Inc., Vetter Pharma, Recipharm AB, Aenova Group, Fresenius Kabi, Unither Pharmaceuticals, Famar, Cipla Inc., NextPharma Technologies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Sterile Injectable Contract Manufacturing Market

Product ID: UCMIG35I2298

$5,300
BUY NOW GET FREE SAMPLE